Klein Matthew B. sold PTCT
April 21, 2026 · Form 4 insider transaction
Klein Matthew B. sold 2,850 shares of PTC Therapeutics, Inc. at $70.91 per share, a transaction worth $202.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,850
Price
$70.91
Total value
$202.1K
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 21, 2026
Filing dateApril 23, 2026
Shares owned after394,070
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from an April 18, 2023 grant of 26,000 RSUs.